Alemtuzumab improves contrast sensitivity in patients with relapsing-remitting multiple sclerosis.
Graves J; Galetta SL; Palmer J; Margolin DH; Rizzo M; Bilbruck J; Balcer LJ; Multiple Sclerosis (Houndmills, Basingstoke, England), 2013, vol. 19, issue 10, p 1302, ISSN 14770970. ISBN 14770970.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef